Dr. Mohammad Mashayekh, MD

NPI: 1700224656
Total Payments
$809.13
2024 Payments
$335.32
Companies
14
Transactions
43
Medicare Patients
75
Medicare Billing
$5,978

Payment Breakdown by Category

Food & Beverage$809.13 (100.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $809.13 43 100.0%

Top Paying Companies

Company Total Records Latest Year
Alkermes, Inc. $193.52 10 $0 (2024)
Indivior Inc. $177.35 10 $0 (2024)
ABBVIE INC. $142.47 7 $0 (2024)
Orexo US, Inc. $66.84 4 $0 (2024)
USWM, LLC $51.55 3 $0 (2024)
Janssen Pharmaceuticals, Inc $25.89 1 $0 (2024)
Neos Therapeutics, LP $24.91 1 $0 (2024)
Axsome Therapeutics, Inc. $24.57 1 $0 (2024)
E.R. Squibb & Sons, L.L.C. $24.19 1 $0 (2024)
Otsuka Pharmaceutical Development & Commercialization, Inc. $19.19 1 $0 (2019)

Payment History by Year

Year Amount Transactions Top Company
2024 $335.32 16 Alkermes, Inc. ($67.62)
2023 $163.82 9 ABBVIE INC. ($63.80)
2022 $93.12 6 Alkermes, Inc. ($32.54)
2021 $92.29 6 Alkermes, Inc. ($33.72)
2020 $39.62 2 Indivior Inc. ($21.44)
2019 $84.96 4 Indivior Inc. ($28.85)

All Payment Transactions

43 individual payment records from CMS Open Payments — Page 1 of 2

Date Company Product Nature Form Amount Type
11/21/2024 E.R. Squibb & Sons, L.L.C. COBENFY (Drug) Food and Beverage Cash or cash equivalent $24.19 General
Category: Psychiatry/Psychology
11/07/2024 Orexo US, Inc. Zubsolv (Drug) Food and Beverage Cash or cash equivalent $15.56 General
Category: Addiction Medicine
10/10/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $22.91 General
Category: NEUROSCIENCE
10/08/2024 Indivior Inc. SUBLOCADE (Drug) Food and Beverage In-kind items and services $23.54 General
Category: OUD
09/30/2024 Alkermes, Inc. LYBALVI (Drug), LYBALVI, LYBALVI Food and Beverage In-kind items and services $22.43 General
Category: CNS
09/26/2024 Janssen Pharmaceuticals, Inc INVEGA SUSTENNA (Drug) Food and Beverage In-kind items and services $25.89 General
Category: Neuroscience
09/24/2024 USWM, LLC Lucemyra (Drug) Food and Beverage In-kind items and services $19.26 General
Category: Psychiatry/Psychology
09/24/2024 USWM, LLC Lucemyra (Drug) Food and Beverage In-kind items and services $16.42 General
Category: Psychiatry/Psychology
09/10/2024 Alkermes, Inc. ARISTADA (Drug), ARISTADA, ARISTADA Food and Beverage In-kind items and services $19.27 General
Category: CNS
06/12/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $21.26 General
Category: NEUROSCIENCE
05/28/2024 Neos Therapeutics, LP Adzenys XR-ODT (Drug) Food and Beverage Cash or cash equivalent $24.91 General
Category: ADHD
05/14/2024 Alkermes, Inc. VIVITROL (Drug) Food and Beverage In-kind items and services $25.92 General
Category: CNS
05/02/2024 USWM, LLC Lucemyra (Drug) Food and Beverage In-kind items and services $15.87 General
Category: Psychiatry/Psychology
04/24/2024 Indivior Inc. SUBLOCADE (Drug) Food and Beverage In-kind items and services $15.51 General
Category: OUD
02/29/2024 Axsome Therapeutics, Inc. Auvelity (Drug) Food and Beverage In-kind items and services $24.57 General
Category: Psychology/Psychiatric
01/24/2024 Braeburn Inc. BRIXADI (Drug) Food and Beverage In-kind items and services $17.81 General
Category: Opioid Use Disorder
11/16/2023 Indivior Inc. SUBLOCADE (Drug) Food and Beverage In-kind items and services $18.94 General
Category: OUD
11/08/2023 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $26.20 General
Category: NEUROSCIENCE
08/10/2023 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $15.91 General
Category: NEUROSCIENCE
07/25/2023 Indivior Inc. SUBLOCADE (Drug) Food and Beverage In-kind items and services $12.94 General
Category: OUD
06/14/2023 Indivior Inc. PERSERIS (Drug) Food and Beverage In-kind items and services $14.25 General
Category: BH
04/12/2023 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $21.69 General
Category: NEUROSCIENCE
04/10/2023 BioXcel Therapeutics, Inc. IGALMI (Drug) Food and Beverage In-kind items and services $13.23 General
Category: NEUROSCIENCE
03/09/2023 Alkermes, Inc. Vivitrol (Drug) Food and Beverage In-kind items and services $20.69 General
Category: CNS
02/14/2023 Orexo US, Inc. Zubsolv (Drug) Food and Beverage Cash or cash equivalent $19.97 General
Category: Addiction Medicine

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 1 21 25 $5,586 $1,806
2021 1 24 27 $5,696 $1,791
2020 1 30 38 $8,094 $2,381
Total Patients
75
Total Services
90
Medicare Billing
$5,978
Procedure Codes
3

All Medicare Procedures & Services

3 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes Facility 2023 21 25 $5,586 $1,806 32.3%
99232 Subsequent hospital inpatient care, typically 25 minutes per day Facility 2021 24 27 $5,696 $1,791 31.4%
99232 Subsequent hospital inpatient care, typically 25 minutes per day Facility 2020 30 38 $8,094 $2,381 29.4%

About Dr. Mohammad Mashayekh, MD

Dr. Mohammad Mashayekh, MD is a Student in an Organized Health Care Education/Training Program healthcare provider based in Bronx, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/12/2013. The National Provider Identifier (NPI) number assigned to this provider is 1700224656.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mohammad Mashayekh, MD has received a total of $809.13 in payments from pharmaceutical and medical device companies, with $335.32 received in 2024. These payments were reported across 43 transactions from 14 companies. The most common payment nature is "Food and Beverage" ($809.13).

As a Medicare-enrolled provider, Mashayekh has provided services to 75 Medicare beneficiaries, totaling 90 services with total Medicare billing of $5,978. Data is available for 3 years (2020–2023), covering 3 distinct procedure/service records.

Practice Information

Products in Payments

  • SUBLOCADE (Drug) $163.10
  • VRAYLAR (Drug) $142.47
  • VIVITROL (Drug) $112.95
  • Zubsolv (Drug) $66.84
  • Lucemyra (Drug) $51.55
  • ARISTADA (Drug) $37.45
  • INVEGA SUSTENNA (Drug) $25.89
  • Adzenys XR-ODT (Drug) $24.91
  • Auvelity (Drug) $24.57
  • COBENFY (Drug) $24.19
  • LYBALVI (Drug) $22.43
  • Vivitrol (Drug) $20.69
  • BRIXADI (Drug) $17.81
  • REXULTI (Drug) $16.15
  • PERSERIS (Drug) $14.25
  • IGALMI (Drug) $13.23
  • CAPLYTA (Drug) $11.46

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Student in an Organized Health Care Education/Training Program Doctors in Bronx